Literature DB >> 28195223

Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis.

K Kuchta1, Y Xiang2, S Huang2, Y Tang2, X Peng2, X Wang2, Y Zhu2, J Li2, J Xu2, Z Lin2, T Pan2.   

Abstract

BACKGROUND: Treatment failure of prostate cancer (PCa) is often due to bone metastasis. Celastrol, an active constituent of Tripterygium wilfordii roots, has shown anti-tumor effects in previous studies in accordance with its indication in traditional Chinese medicine.
METHODS: Using a PC-3 cell model, in vitro assays were performed to evaluate the effects of celastrol on proliferation, migration (wound healing assay), tissues invasion (Transwell-Matrigel penetration assay) and vascular endothelial growth factor (VEGF) secretion (enzyme-linked immunosorbent assay). An intra-tibia injection mouse model was used to assess the effect of celastrol on PCa bone metastasis in vivo.
RESULTS: Pretreatment with celastrol significantly reduced proliferation of PC-3 cells in a dose-dependent manner and cell migration was much slower than in controls. Significantly fewer cells penetrated the gel-membrane after celastrol administration and their skeletal invasive ability was significantly reduced in a dose-dependent manner. Correspondingly, a significant, dose-dependent decrease in VEGF secretion was observed. In the in vivo mouse model, pretreatment with celastrol (8 μmol l-1) inhibited the tumorigenicity of PC-3 cells so that almost no bone invasion occurred as compared with control injections. Histological examinations using hematoxylin and eosin staining showed that tibiae injected with celastrol pretreated PC-3 cells retained their natural bone structure.
CONCLUSIONS: Celastrol may have preventive potential against PCa bone metastasis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28195223     DOI: 10.1038/pcan.2016.61

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  22 in total

Review 1.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

2.  The white adipose tissue used in lipotransfer procedures is a rich reservoir of CD34+ progenitors able to promote cancer progression.

Authors:  Ines Martin-Padura; Giuliana Gregato; Paola Marighetti; Patrizia Mancuso; Angelica Calleri; Chiara Corsini; Giancarlo Pruneri; Michela Manzotti; Visnu Lohsiriwat; Mario Rietjens; Jean-Yves Petit; Francesco Bertolini
Journal:  Cancer Res       Date:  2011-11-03       Impact factor: 12.701

3.  Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells.

Authors:  F A Ferrer; L J Miller; R I Andrawis; S H Kurtzman; P C Albertsen; V P Laudone; D L Kreutzer
Journal:  J Urol       Date:  1997-06       Impact factor: 7.450

4.  Hypoxia of PC-3 prostate cancer cells enhances migration and vasculogenesis in vitro of bone marrow-derived endothelial progenitor cells by secretion of cytokines.

Authors:  Shuai Huang; Longyun Peng; Yubo Tang; Longjuan Zhang; Wei Guo; Xuenong Zou; Xinsheng Peng
Journal:  Oncol Rep       Date:  2013-03-26       Impact factor: 3.906

5.  A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer.

Authors:  C J Paller; X Ye; P J Wozniak; B K Gillespie; P R Sieber; R H Greengold; B R Stockton; B L Hertzman; M D Efros; R P Roper; H R Liker; M A Carducci
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-06-12       Impact factor: 5.554

6.  Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization.

Authors:  Daniel J Nolan; Alessia Ciarrocchi; Albert S Mellick; Jaspreet S Jaggi; Kathryn Bambino; Sunita Gupta; Emily Heikamp; Michael R McDevitt; David A Scheinberg; Robert Benezra; Vivek Mittal
Journal:  Genes Dev       Date:  2007-06-15       Impact factor: 11.361

7.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

8.  Patterns of bone metastasis and their prognostic significance in patients with carcinoma of the prostate.

Authors:  A Rana; G D Chisholm; M Khan; S S Sekharjit; M V Merrick; R A Elton
Journal:  Br J Urol       Date:  1993-12

9.  The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations.

Authors:  Anna Dubrovska; Sungeun Kim; Richard J Salamone; John R Walker; Sauveur-Michel Maira; Carlos García-Echeverría; Peter G Schultz; Venkateshwar A Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-30       Impact factor: 11.205

Review 10.  The main anticancer bullets of the Chinese medicinal herb, thunder god vine.

Authors:  Zi Liu; Liang Ma; Guang-Biao Zhou
Journal:  Molecules       Date:  2011-06-23       Impact factor: 4.411

View more
  13 in total

Review 1.  Therapeutic potential of traditional Chinese medicine for vascular endothelial growth factor.

Authors:  Yijia Mao; Lingkai Meng; Huayi Liu; Yuting Lu; Kuo Yang; Guangze Ouyang; Yanran Ban; Shuang Chen
Journal:  J Zhejiang Univ Sci B       Date:  2022-05-15       Impact factor: 5.552

2.  Zebrafish as an alternative method for determining the embryo toxicity of plant products: a systematic review.

Authors:  Maria Alice Pimentel Falcão; Lucas Santos de Souza; Silvio Santana Dolabella; Adriana Gibara Guimarães; Cristiani Isabel Banderó Walker
Journal:  Environ Sci Pollut Res Int       Date:  2018-10-24       Impact factor: 4.223

3.  Celastrol pretreatment as a therapeutic option against cisplatin-induced nephrotoxicity.

Authors:  Tugce Boran; Aysenur Gunaydin; Ayse Tarbin Jannuzzi; Eren Ozcagli; Buket Alpertunga
Journal:  Toxicol Res (Camb)       Date:  2019-07-31       Impact factor: 3.524

Review 4.  Chinese Medicines in the Treatment of Prostate Cancer: From Formulas to Extracts and Compounds.

Authors:  Xueni Wang; Gang Fang; Yuzhou Pang
Journal:  Nutrients       Date:  2018-02-28       Impact factor: 5.717

5.  Protective effects of celastrol against γ irradiation-induced oxidative stress in human umbilical vein endothelial cells.

Authors:  Xiang-Bei Han; Yan Tan; Yan-Qiu Fang; Feng Li
Journal:  Exp Ther Med       Date:  2018-06-07       Impact factor: 2.447

6.  Tripterine up-regulates miR-223 to alleviate lipopolysaccharide-induced damage in murine chondrogenic ATDC5 cells.

Authors:  Xuefu Li; Wei Wei; Zhongquan Zhao; Shuzhen Lv
Journal:  Int J Immunopathol Pharmacol       Date:  2019 Jan-Dec       Impact factor: 3.219

7.  Anti-Tumor Effect of Celastrol on Hepatocellular Carcinoma by the circ_SLIT3/miR-223-3p/CXCR4 Axis.

Authors:  Hailong Si; Huiling Wang; Haijuan Xiao; Yu Fang; Zhaoli Wu
Journal:  Cancer Manag Res       Date:  2021-02-05       Impact factor: 3.989

8.  Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis.

Authors:  Kui Zhang; Gang Fu; Guangzhao Pan; Chongyang Li; Li Shen; Renjian Hu; Shunqin Zhu; Yibiao Chen; Hongjuan Cui
Journal:  Cell Death Dis       Date:  2018-10-10       Impact factor: 8.469

Review 9.  Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets.

Authors:  Fabrizio Fontana; Michela Raimondi; Monica Marzagalli; Alessandro Di Domizio; Patrizia Limonta
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

10.  Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles.

Authors:  Zhanrong Li; Zhihua Guo; Dandan Chu; Huayang Feng; Junjie Zhang; Lei Zhu; Jingguo Li
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.